Health and Medical Guide to Eyes and Vision Eyes and Vision Health information topics about Eyes and Vision: Age-Related Macular Degeneration (Macular Degeneration) AMD (Macular Degeneration) Anatomy (Anatomy) Astigmatism (Refractive Errors) Behcet's Syndrome (Behcet's Syndrome) Blindness (Vision Impairment and Blindness) Cataract (Cataract) Conjunctivitis (Eye Diseases) Contact Lenses (Eye Wear) Diabetic Eye Problems (Diabetic Eye Problems) Eye Cancer (Eye Cancer) Eye Diseases (Eye Diseases) Eye Injuries (Eye Injuries) Eye Wear (Eye Wear) Farsightedness (Refractive Errors) Floater (Retinal Disorders) Glasses (Eye Wear) Glaucoma (Glaucoma) Hyperopia (Refractive Errors) Intraocular Melanoma (Eye Cancer, Melanoma) Laser Eye Surgery (Laser Eye Surgery) LASIK (Laser Eye Surgery) Low Vision (Vision Impairment and Blindness) Macular Degeneration (Macular Degeneration) Myopia (Refractive Errors) Nearsightedness (Refractive Errors) Nystagmus (Eye Diseases) Ophthalmology (Eye Diseases) Pink Eye (Eye Diseases) Protective Eye Wear (Eye Injuries) Refractive Errors (Refractive Errors) Retinal Disorders (Retinal Disorders) Retinoblastoma (Eye Cancer) Strabismus (Eye Diseases) Vision Impairment and Blindness (Vision Impairment and Blindness   Eye Health / Blindness News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside The Uni... 5 Sep 2010 at 2:00am Alcon, Inc. (NYSE: ACL), the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France... Starting The School Year Right 4 Sep 2010 at 4:00am As many children head back to school this fall, are they truly prepared for what lies ahead? With a few simple medical exams; Maine's school-age children will be armed with the tools they need to have a healthier school year... Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium 3 Sep 2010 at 7:00am Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept... 'Back-To-School' How To Prevent Sports Related Eye Injuries 3 Sep 2010 at 6:00am It's back to school time! Kids are feeling excited and maybe a little nervous. New teachers, new friends and new sports seasons. Parents are scrambling to buy back-to-school clothes and equip their children with all the sports gear they need, like helmets, pads, braces and mouth guards... Carl Zeiss Meditec Is Shaping The Future Of Ophthalmology: Creating What's To... 3 Sep 2010 at 5:00am Carl Zeiss Meditec is once again presenting its expanded offer of solutions for cataract, refractive and retina applications. Under the theme - Creating what's to come - the company is demonstrating how it would like to shape the future of ophthalmology with its products and solutions... OptiMedica's Laser Cataract Surgery System To Be Featured In Three Clinical P... 3 Sep 2010 at 4:00am Global ophthalmic device company OptiMedica Corp. has announced that clinical results for its laser cataract surgical system will be the subject of three presentations at the European Society of Cataract and Refractive Surgeons annual meeting in Paris, September 4 - 8... Dr. Tom Tooma Purchases Interest In All 12 Southern California TLC Laser Eye ... 2 Sep 2010 at 8:00am All 12 TLC Laser Eye Centers in Southern California are changing their names to NVISION Laser Eye Centers. The name change accompanies the sale of TLC Vision's interest in the 12 centers to Medical Director Dr. Tom Tooma to become a separate LASIK brand. The new brand will operate as NVISION Laser Eye Centers and will have the same 12 Southern California locations, same surgeons and staff... Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps 2 Sep 2010 at 6:00am Bausch + Lomb Storz® Ophthalmic Instruments announces the U.S. release of a new, single-use, asymmetric peeling forceps for vitreoretinal surgery. The forceps are available in 23- and 25-gauge options for facilities seeking the safety, consistency and convenience a single-use instrument offers... New Data Will Help Predict Vision Loss In Glaucoma 2 Sep 2010 at 6:00am Eye M.D.s are intent on finding better ways to diagnose and treat glaucoma, a complex, potentially blinding disease. September's Ophthalmology journal includes new data from the Rotterdam Study that will help doctors better predict visual field loss (VFL) in glaucoma patients. Johannes R... Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2 Sep 2010 at 4:00am A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)... ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovasculariza... 2 Sep 2010 at 4:00am ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D... Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirm... 2 Sep 2010 at 4:00am ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint... pSivida Announces Iluvien(R) Receives FDA Priority Review For Treatment Of Di... 2 Sep 2010 at 3:00am pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has been notified that the U.S... Allergan Receives FDA Approval For LUMIGAN(R) 0.01% As First-Line Therapy Ind... 2 Sep 2010 at 2:00am Allergan, Inc. (NYSE:AGN) announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LUMIGAN® 0... Improving Ocular Disease Screening By LED Illumination Of The Eye 1 Sep 2010 at 6:00am A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular degeneration and diabetic retinopathy. The system is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics...     HealthBusinessBuilder.com Build your Health Business Fast!